HomeNewsBusinessReal EstateAffordable housing firm Signature Global plans launch of 10,000 units by March 2021

Affordable housing firm Signature Global plans launch of 10,000 units by March 2021

Gurgaon-based firm Signature Global's target to launch 30,000 affordable housing units this year is on track

August 10, 2020 / 13:14 IST
Story continues below Advertisement

A Gurgaon-based real estate developer, Signature Global Group, which is into affordable housing projects, plans to launch 10,000 units before March 2021 as per the target it had set in pre-COVID times.

This month it launched over 800 units under the Deen Dayal Jan Awas Yojana, a scheme by the Haryana government under which it intends developing two lakh affordable housing units by 2022. The company has invested Rs 400 crore on this project so far.

Story continues below Advertisement

“We acquired the land over a year ago and financial institutions we had lined up before COVID-19 such as HDFC Capital, KKR etc have supported us for this project,” Pradeep Aggarwal, Founder and Chairman, Signature Global told Moneycontrol.

He claimed that affordable housing is one segment that has not been badly impacted by the pandemic.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show